文献速递胸部外周血管CT

健康、ARDS与COVID-19肺的通气和肺血容量分布:双能CT回顾性队列研究

Distribution of Aeration and Pulmonary Blood Volume in Healthy, ARDS and COVID-19 Lungs: A Dual-Energy Computed Tomography Retrospective Cohort Study.
PubMed 文献 · Acad Radiol · 2023-01-19

本研究利用双能CT肺动脉造影回顾性分析20例COVID-19(10轻、10中重)、6例非COVID ARDS(NC-ARDS)和12例健康对照的肺通气和血容量分布。结果显示重症COVID-19总通气肺体积最低,磨玻璃影区血容量最低,而正常通气区血容量较高;通气/血容量比值在重症COVID-19最低,但与NC-ARDS有重叠。

要点

  • 重症COVID-19表现为总通气肺体积低、磨玻璃影区血容量低、正常通气区血容量高。
  • 通气/血容量比值在重症COVID-19最低,但部分值与NC-ARDS重叠,鉴别需谨慎。
  • 双能CT可定量评估肺通气与血容量分布,辅助理解不同病因肺损伤的病理生理差异。

关键影像表现/征象

  • 肺通气最低见于重症COVID-19(24%,IQR 13%-31%),其次为NC-ARDS(40%,IQR 21%-46%)。
  • 磨玻璃影区血容量最低见于COVID-19(中重度:-28.6,IQR -33.1至-23.2;轻度:-30.1,IQR -33.3至-23.4)。
  • 正常通气区血容量最高见于NC-ARDS(-37.4,IQR -52.5至-30.2)和中重度COVID-19(-33.5,IQR -44.2至-28.5)。

诊断标准与关键数值

  • NC-ARDS诊断采用柏林标准。
  • 中位通气/血容量比值在重症COVID-19最低,但部分值与NC-ARDS重叠。

临床应用与阅片要点

  • 双能CT肺动脉造影可同时评估肺通气与血容量分布,辅助鉴别COVID-19与其他原因ARDS。
  • 阅片时注意磨玻璃影区血容量减低及正常肺区血容量增高可能提示重症COVID-19。
  • 通气/血容量比值重叠提示不能单独依靠该指标鉴别COVID-19与NC-ARDS。

局限性

  • 研究为假设生成性,部分指标组间重叠,鉴别能力有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Few reports have studied lung aeration and perfusion in normal lungs, COVID-19, and ARDS from other causes (NC-ARDS) using dual-energy computed tomography pulmonary angiograms (DE-CTPA). To describe lung aeration and blood-volume distribution using DE-CTPAs of patients with NC-ARDS, COVID-19, and controls with a normal DE-CTPA ("healthy lungs"). We hypothesized that each of these conditions has unique ranges of aeration and pulmonary blood volumes.

MATERIALS AND METHODS: This retrospective, single-center study of DE-CTPAs included patients with COVID-19, NC-ARDS (Berlin criteria), and controls. Patients with macroscopic pulmonary embolisms were excluded. The outcomes studied were the (1) lung blood-volume in areas with different aeration levels (normal, ground glass opacities [GGO], consolidated lung) and (2) aeration/blood-volume ratios.

RESULTS: Included were 20 patients with COVID-19 (10 milds, 10 moderate-severe), six with NC-ARDS, and 12 healthy-controls. Lung aeration was lowest in patients with severe COVID-19 24% (IQR13%-31%) followed by those with NC-ARDS 40%(IQR21%-46%). Blood-volume in GGO was lowest in patients with COVID-19 [moderate-severe:-28.6 (IQR-33.1-23.2); mild: -30.1 (IQR-33.3-23.4)] and highest in normally aerated areas in NC-ARDS -37.4 (IQR-52.5-30.2-) and moderate-severe COVID-19 -33.5(IQR-44.2-28.5). The median aeration/blood-volume ratio was lowest in severe COVID-19 but some values overlapped with those observed among patients with NC-ARDS.

CONCLUSION: Severe COVID-19 disease is associated with low total aerated lung volume and blood-volume in areas with GGO and overall aeration/blood volume ratios, and with high blood volume in normal lung areas. In this hypothesis-generating study, these findings were most pronounced in severe COVID disease. Larger studies are needed to confirm these preliminary findings.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Bogot, Steiner, Helviz, et al. Distribution of Aeration and Pulmonary Blood Volume in Healthy, ARDS and COVID-19 Lungs: A Dual-Energy Computed Tomography Retrospective Cohort Study. Acad Radiol. 2023. PMID: 36966073. doi:10.1016/j.acra.2023.01.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。